✦ LIBER ✦

Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

✍ Scribed by Aspasia Stamatoullas; Christophe Fruchart; Dominique Bastit; Dominique Boulet; Mathieu Monconduit; Hubert Piguet; Hervé Tilly

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 567 KB
Volume: 77
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19960601)77:11<2302::aid-cncr18>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine-based combination chemothera

Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma

✍ Shih-Hung Yang; Zhong-Zhe Lin; Sung-Hsin Kuo; Ann-Lii Cheng 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Etoposide, ifosfamide and methotrexate c

Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-hodgkin's lymphoma after failure of the LNH 84 regimen

✍ R. Herbrecht; S. Ortiz; J. C. Damonte; K. L. Liu; F. Maloisel; P. Dufour; J. P. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

We assessed the efficacy of an etoposide, ifosfamide and methotrexate combination therapy (VIM) in 24 patients failing the LNH 84 protocol. Eight of these patients were refractory to the LNH 84 induction regimen, 10 were partial responders and the six remaining attained complete response after LNH 8

Radiotherapy as salvage treatment in pat

Radiotherapy as salvage treatment in patients with hodgkin's disease or non-hodgkin's lymphoma relapsing after initial chemotherapy

✍ Carine Kirkove; Adrian R. Timothy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract The prognosis of relapsing Hodgkin's disease (HD) and high grade aggressive non‐Hodgkin's lymphoma (NHL) is generally poor since many of these patients fail to respond to second line chemotherapy. Radiation therapy has been reported as an effective but seldom used, alternative treatment

Dexamethasone, etoposide, ifosfamide, an

Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-hodgkin's lymphoma

✍ Nissim Haim; Menachem Ben-Shahar; David Faraggi; Avital Tsuri-Etzioni; Michelle 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. This study analyzed the long term results of a combination of dexa-

Oxaliplatin-based chemotherapy (dexameth

Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma

✍ Luigi Rigacci; Alberto Fabbri; Benedetta Puccini; Ida Chitarrelli; Annalisa Chia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

VIM3-ARA C: An effective salvage regimen

VIM3-ARA C: An effective salvage regimen in refractory or recurrent aggressive non hodgkin's lymphoma. A report on 18 cases

✍ Brigitte Dupriez; Pierre Morel; Pierre Fenaux; Isabelle Colcher-Plantier; Thierr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Based on encouraging results of previous combination regimens, we used a combination of VM26, ifosfamide, methylGAG, mitoxantrone (or adriamycin), high-dose (HD) methotrexate and HD Ara C to treat 18 patients with relapsed or refractory NHL. Front-line therapy had been in most of them a reinforced C